ABOUT CITRINE S A L
Citrine S A L is a leading technology-focused investment group that enables Israeli entrepreneurs to materialize global breakthrough technology companies.
Citrine technology funds include the management of Limited Partnerships by Citrine S A L High-Tech and Citrine S A L Biotech that operate as Managing Partners.
The partnerships are registered as Limited Partnerships with the Registrar of Partnerships in Israel and include a variety of options for investment periods, fields of expertise, risk levels, profitability levels and protections that allow the investor to diversify his investment and minimize risk.
Citrine Global Corp. (OTCQB: CTGL):
Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) develops strategic solutions for technology industries with global growth potential in the high-tech and biotech fields, which include supportive environments that combine, among other things, entrepreneurship and the establishment of innovation centers for production, operations, R&D, marketing, export, assistance in building strategy for realizing the potential, and more.
Our focus areas:
-
medical devices
-
digital health
-
cannabis technologies
-
wellness solutions
-
personalized medicine
-
block chain solutions
-
biotechnology
-
diagnosis/prevention
-
clean-tech
-
green energy
-
cyber technology
-
Media
-
Internet of Things
Citrine is part of:
• WealthStone Group, that specializes in Alternative Investment in various fields , Hedge Funds , Real-estate and Technology
• Neto Finance , one of the largest insurance & finance adviser firms in Israel managing 7B NIS for private client & investors.
In the past 5 years, the group has raised over $300M from Israeli private investors setting up ~70 partnerships in various fields.
The group targets to manage in the next 7 years $1B Dollar for private & international investors.
